With COVID-19 vaccination rates reaching the double dose rate for the states and territories to open up, Australia is poised to begin living with COVID-19.
While the vast majority of Australians welcome reduced restrictions, the physical and psychological implications for people with compromised immune systems may, understandably, lead to increased anxiety.
We, therefore, welcome the announcement by the Australian Technical Advisory Group (ATAGI) recommending booster shots of the COVID-19 vaccine for people who are severely immunocompromised and might not be fully protected by the regular two doses of a vaccine.
Recommendations specific to the 3rd dose:
Among the eligible groups, ATAGI has identified people with active haematological malignancies, people with cancer on current active treatment including chemotherapy, radiotherapy, and/or hormonal therapy, but excluding immunotherapy with immune checkpoint inhibitors, and some immunosuppressive therapies for chronic conditions.
More information on the ATAGI recommendation can be found below.